The effect of afatinib in a pretreated patient with invasive mucinous adenocarcinoma of the lung harboring HER2 YVMA insertion: a case report

BACKGROUND: Invasive mucinous adenocarcinoma (IMA) is an uncommon variant of lung adenocarcinoma. The survival data and therapeutic methods for IMAs are limited. The frequency of human epidermal growth factor receptor 2 (HER2) mutations in IMAs is low, and the clinical benefit of HER2 inhibitors in...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Yueming, Huang, Hong, Xu, Meng, Fu, Zhihui, Zhang, Xiang’e, Chen, Xiaoyan, Guo, Weifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273679/
https://www.ncbi.nlm.nih.gov/pubmed/35836522
http://dx.doi.org/10.21037/tcr-22-1457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273679/
https://www.ncbi.nlm.nih.gov/pubmed/35836522
http://dx.doi.org/10.21037/tcr-22-1457

Ejemplares similares